The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant ...

How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...

The American Association for Cancer Research’s annual conference continued Tuesday with Marengo Therapeutics making progress ...

Ingelheim, Germany Wednesday, April 30, 2025, 14:00 Hrs [IST] ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

Results presented on Tuesday at the American Association for Cancer Reserch include data on the combined use of tissue and ...

Emma Dimery joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

The FDA has recently approved AstraZeneca’s Imfinzi (durvalumab) for perioperative use in cisplatin-eligible muscle-invasive ...

Data from the NERO study investigating Zejula in mesothelioma was presented at the American Association of Cancer Research ...

Q1 2025 Earnings Call Transcript April 29, 2025 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

A good performance from generics was driven by the successful recent launch of paclitaxel, as well as continued strong growth in Canada. Biosimilar net-sales growth would have been positive when ...

Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes ...